Coramed Technologies

Niles, IL 60714

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $4.04MM
First Award Date 05/20/08
Most Recent Award Date 06/01/13

Key Personnel

Last Name Name Awards Contact
Raviv Gabriel Raviv 5

5 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 06/01/13 - 05/31/14

DESCRIPTION (provided by applicant): Coramed is commercializing next-generation point of care instruments, the TEG 6000 series, for monitoring patient hemostasis on demand. This project includes activities to take the technology from the prototype stage completed in Phase II to FDA-cleared and CLIA-waived commercial products. The planned devices...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 06/01/12 - 05/31/13

DESCRIPTION (provided by applicant): Coramed is commercializing next-generation point of care instruments, the TEG 6000 series, for monitoring patient hemostasis on demand. This project includes activities to take the technology from the prototype stage completed in Phase II to FDA-cleared and CLIA-waived commercial products. The planned devices...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 06/01/11 - 05/31/12

DESCRIPTION (provided by applicant): Coramed is commercializing next-generation point of care instruments, the TEG 6000 series, for monitoring patient hemostasis on demand. This project includes activities to take the technology from the prototype stage completed in Phase II to FDA-cleared and CLIA-waived commercial products. The planned devices...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 06/01/09 - 05/31/10

DESCRIPTION (provided by applicant): Coramed is designing a next-generation point-of-care (POC) instrument, the TEG 6500, for monitoring patient hemostasis on demand. The instrument will introduce a completely new technology for monitoring clot formation and breakdown that is well suited for the continuum of settings from inside the hospital, to...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 05/20/08 - 11/30/08

DESCRIPTION (provided by applicant): Nearly 2 million people are hospitalized each year for ischemic events. To minimize the risk of recurrent events, nearly all patients are prescribed aspirin or other antiplatelet therapy and 86% are prescribed anticoagulants upon discharge. Anticoagulation and antiplatelet therapy requires frequent monitoring...